Us Bancorp \De\ Neogenomics Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Neogenomics Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 1,815 shares of NEO stock, worth $25,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,815

Previous 2,578 29.6%

Holding current value

$25,319

Previous $35,000 25.71%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$13.4 - $17.73 $10,224 - $13,527	-763 Reduced 29.6%	1,815 $26,000
Q2 2024 Aug 06, 2024	SELL	$13.01 - $15.77 $6,830 - $8,279	-525 Reduced 16.92%	2,578 $35,000
Q1 2024 May 07, 2024	BUY	$14.06 - $16.79 $12,527 - $14,959	891 Added 40.28%	3,103 $48,000
Q4 2023 Feb 09, 2024	BUY	$11.67 - $20.73 $5,193 - $9,224	445 Added 25.18%	2,212 $35,000
Q3 2023 Nov 03, 2023	SELL	$12.15 - $17.85 $11,992 - $17,617	-987 Reduced 35.84%	1,767 $21,000
Q2 2023 Aug 09, 2023	SELL	$14.1 - $19.83 $5,047 - $7,099	-358 Reduced 11.5%	2,754 $44,000
Q1 2023 May 09, 2023	SELL	$9.09 - $19.45 $20,034 - $42,867	-2,204 Reduced 41.46%	3,112 $54,000
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $28,399 - $53,144	-4,403 Reduced 45.3%	5,316 $49,000
Q3 2022 Oct 27, 2022	SELL	$7.86 - $12.91 $23,894 - $39,246	-3,040 Reduced 23.83%	9,719 $84,000
Q2 2022 Aug 01, 2022	SELL	$7.06 - $13.97 $16,061 - $31,781	-2,275 Reduced 15.13%	12,759 $104,000
Q1 2022 May 11, 2022	SELL	$12.15 - $35.28 $130,952 - $380,247	-10,778 Reduced 41.76%	15,034 $184,000
Q4 2021 Feb 11, 2022	BUY	$30.49 - $48.49 $27,562 - $43,834	904 Added 3.63%	25,812 $882,000
Q3 2021 Nov 10, 2021	SELL	$41.66 - $52.52 $211,507 - $266,644	-5,077 Reduced 16.93%	24,908 $1.2 Million
Q2 2021 Aug 05, 2021	BUY	$36.62 - $51.69 $9,814 - $13,852	268 Added 0.9%	29,985 $1.36 Million
Q1 2021 Apr 28, 2021	SELL	$41.56 - $59.88 $61,508 - $88,622	-1,480 Reduced 4.74%	29,717 $1.43 Million
Q4 2020 Feb 04, 2021	BUY	$36.08 - $56.47 $2,922 - $4,574	81 Added 0.26%	31,197 $1.68 Million
Q3 2020 Nov 10, 2020	BUY	$33.26 - $40.48 $405,273 - $493,248	12,185 Added 64.37%	31,116 $1.15 Million
Q2 2020 Aug 07, 2020	SELL	$24.21 - $31.02 $80,958 - $103,730	-3,344 Reduced 15.01%	18,931 $586,000
Q1 2020 May 13, 2020	BUY	$20.5 - $34.53 $47,375 - $79,798	2,311 Added 11.58%	22,275 $615,000
Q4 2019 Feb 04, 2020	SELL	$18.96 - $29.84 $53,789 - $84,656	-2,837 Reduced 12.44%	19,964 $583,000
Q3 2019 Nov 08, 2019	SELL	$19.12 - $26.24 $55,486 - $76,148	-2,902 Reduced 11.29%	22,801 $435,000
Q2 2019 Aug 13, 2019	BUY	$19.57 - $24.1 $469,288 - $577,918	23,980 Added 1391.76%	25,703 $565,000
Q1 2019 May 08, 2019	SELL	$12.14 - $20.46 $2,306 - $3,887	-190 Reduced 9.93%	1,723 $35,000
Q4 2018 Feb 13, 2019	SELL	$11.24 - $18.5 $16,758 - $27,583	-1,491 Reduced 43.8%	1,913 $25,000
Q3 2018 Nov 01, 2018	BUY	$12.5 - $15.38 $18,637 - $22,931	1,491 Added 77.94%	3,404 $52,000
Q1 2018 May 08, 2018	SELL	$7.23 - $8.76 $195 - $236	-27 Reduced 1.39%	1,913 $15,000
Q4 2017 Feb 02, 2018	SELL	$8.02 - $11.18 $7,418 - $10,341	-925 Reduced 32.29%	1,940 $17,000
Q3 2017 Nov 13, 2017	BUY	$9.11 - $11.26 $26,100 - $32,259	2,865	2,865 $32,000

Others Institutions Holding NEO

# of Institutions

294

Shares Held

125M

Call Options Held

698K

Put Options Held

116K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.75B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account